Casdin Capital, LLC Q3 2019 Filing
Filed November 12, 2019
Portfolio Value
$745.1B
Holdings
26
Report Date
Q3 2019
Filing Type
13F-HR
All Holdings (26 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —SPARK THERAPEUTICS INC | 863,300 | $83.7B | 11.24% | |
| 2 | NVTA1EURINVITAE CORP | 1,038,388 | $83.6B | 11.22% | |
| 3 | 2L9BLUEPRINT MEDICINES CORP | 940,000 | $69.1B | 9.27% | |
| 4 | SRPTSAREPTA THERAPEUTICS INC | 880,000 | $66.3B | 8.90% | |
| 5 | —MYOKARDIA INC | 1,115,000 | $58.1B | 7.80% | |
| 6 | —BLUEBIRD BIO INC | 612,500 | $56.2B | 7.55% | |
| 7 | SG7SAGE THERAPEUTICS INC | 400,000 | $56.1B | 7.53% | |
| 8 | ALNYALNYLAM PHARMACEUTICALS INC | 600,000 | $48.3B | 6.48% | |
| 9 | AGIOAGIOS PHARMACEUTICALS INC | 935,000 | $30.3B | 4.07% | |
| 10 | —AUDENTES THERAPEUTICS INC | 860,000 | $24.2B | 3.24% | |
| 11 | CDNACAREDX INC | 1,000,000 | $22.6B | 3.03% | |
| 12 | VYGRVOYAGER THERAPEUTICS INC | 1,128,075 | $19.4B | 2.61% | |
| 13 | ILMNILLUMINA INC | 60,000 | $18.3B | 2.45% | |
| 14 | FIXXEURHOMOLOGY MEDICINES INC | 820,000 | $14.8B | 1.99% | |
| 15 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 300,000 | $14.6B | 1.95% | |
| 16 | ADPTADAPTIVE BIOTECHNOLOGIES COR | 463,125 | $13.4B | 1.80% | |
| 17 | ALECALECTOR INC | 811,039 | $11.7B | 1.57% | |
| 18 | DNLIDENALI THERAPEUTICS INC | 650,000 | $10.0B | 1.34% | |
| 19 | —CONSTELLATION PHARMCETICLS I | 1,523,960 | $9.8B | 1.32% | |
| 20 | EDITEDITAS MEDICINE INC | 415,000 | $9.4B | 1.27% | |
| 21 | TWSTTWIST BIOSCIENCE CORP | 300,000 | $7.2B | 0.96% | |
| 22 | FULCFULCRUM THERAPEUTICS INC | 844,285 | $5.3B | 0.71% | |
| 23 | ORTXUSDORCHARD THERAPEUTICS PLC | 310,000 | $3.7B | 0.49% | |
| 24 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 100,000 | $3.4B | 0.46% | |
| 25 | —TURNING POINT THERAPEUTICS I | 75,000 | $2.8B | 0.38% | |
| 26 | STOKSTOKE THERAPEUTICS INC | 130,000 | $2.8B | 0.37% |